Introduction: The preclinical phase of liver cirrhosis is usually prolonged over several years; once clinical events occur, such as, ascites, encephalopathy, variceal bleeding or the development of hepatocellular carcinoma the remaining course of the disease is much shorter and usually fatal9. For liver cirrhosis there still no curable treatment available except for liver transplantation. Aim of study: Assessment of Clinical profile & incidence of pulmonary involvement in patient with cirrhosis of liver. Methods &Materials: Total of 100 cases of liver cirrhosis were assesed between June 2013 and November 2015 with their consent. Detailed history, thourough clinical examination and relevant investigations were done and analyzed.Result: It was observed that 25 percent patient of liver cirrhosis associated with hepatopulmonary syndrome (HPS). Conclusion: Early identification of pulmonary complications in cirrhotic patients is crucial as it affects the prognosis and guides the future management in liver cirrhosis.